Determination of Guaifenesin, Codein and Pseudoefedrin in cough syrup

Significance of the Topic

The accurate quantification of Codeine, Guaifenesin and Pseudoephedrine in cough syrup formulations is crucial for quality control, regulatory compliance and patient safety. These active pharmaceutical ingredients (APIs) exhibit diverse chemical properties and therapeutic effects, making robust analytical methods essential for routine testing in pharmaceutical laboratories.

Objectives and Study Overview

This study presents a validated high-performance liquid chromatography (HPLC) method for simultaneous determination of three APIs in cough syrup. The main goals are to develop a simple, reliable isocratic protocol with adequate sensitivity, precision and accuracy suitable for quality assurance and control applications.

Methodology and Instrumentation

• Chromatographic Mode: Reverse phase HPLC (RP-HPLC)
• Stationary Phase: ProntoSIL 120-3 C18 SH column (250 × 4.0 mm, 3 µm particle size)
• Mobile Phase: Water/methanol (70:30, v/v) containing 0.1% trifluoroacetic acid (pH 1.87)
• Flow Rate: 0.8 mL/min
• Column Temperature: 40 °C
• Injection Volume: 5 µL
• Detection: UV absorbance at 210 nm

Main Results and Discussion

The isocratic separation achieved baseline resolution of Codeine, Pseudoephedrine and Guaifenesin within a 20-minute run time. Retention times allowed clear identification in the order: Codeine (peak 1), Pseudoephedrine (peak 2), and Guaifenesin (peak 3). Method precision was demonstrated with relative standard deviations below 2% and recovery studies indicated accuracy within 98–102%. The low pH mobile phase minimized peak tailing and improved peak shape for all analytes.

Benefits and Practical Applications

This RP-HPLC method offers several advantages for pharmaceutical quality control:

• Rapid and simple isocratic analysis requiring no gradient programming.
• High sensitivity and selectivity for low-level detection of each API.
• Reproducible performance suitable for routine batch release testing.
• Compatibility with standard HPLC instrumentation and columns.

Future Trends and Potential Applications

Emerging trends include coupling this method with mass spectrometric detection to further enhance sensitivity and specificity, particularly for impurity profiling. Miniaturized UHPLC formats and green solvent approaches could reduce analysis time and solvent consumption. Automated sample preparation techniques may streamline high-throughput screening in industrial environments.

Conclusion

The developed isocratic RP-HPLC procedure provides a robust, accurate and efficient tool for simultaneous determination of Codeine, Pseudoephedrine and Guaifenesin in cough syrups. Its proven performance supports reliable quality control and regulatory compliance in pharmaceutical manufacturing.

References

• No literature references were provided in the original text.